Your browser is no longer supported. Please, upgrade your browser.
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.38 Insider Own1.20% Shs Outstand145.92M Perf Week-6.54%
Market Cap485.52M Forward P/E- EPS next Y-0.95 Insider Trans-22.56% Shs Float132.62M Perf Month-7.05%
Income-161.60M PEG- EPS next Q-0.29 Inst Own70.40% Short Float7.03% Perf Quarter-23.44%
Sales- P/S- EPS this Y0.20% Inst Trans4.95% Short Ratio4.19 Perf Half Y-13.16%
Book/sh1.28 P/B2.68 EPS next Y27.50% ROA-70.30% Target Price- Perf Year42.92%
Cash/sh1.40 P/C2.45 EPS next 5Y- ROE-99.70% 52W Range1.74 - 5.24 Perf YTD0.59%
Dividend- P/FCF- EPS past 5Y-11.60% ROI- 52W High-34.54% Beta2.40
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low96.88% ATR0.21
Employees146 Current Ratio3.50 Sales Q/Q- Oper. Margin- RSI (14)38.45 Volatility5.93% 5.23%
OptionableYes Debt/Eq0.00 EPS Q/Q57.20% Profit Margin- Rel Volume1.41 Prev Close3.60
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.22M Price3.43
Recom2.20 SMA20-7.56% SMA50-10.62% SMA200-8.90% Volume3,128,559 Change-4.72%
Sep-17-20Initiated JMP Securities Mkt Outperform $12
Dec-26-19Downgrade Guggenheim Buy → Neutral
Dec-26-19Downgrade Cantor Fitzgerald Overweight → Neutral $17 → $4
Nov-27-19Resumed B. Riley FBR Buy $18
Jul-11-19Initiated B. Riley FBR Buy $18
Mar-15-19Resumed Jefferies Buy $21
Nov-12-18Reiterated B. Riley FBR Buy $35 → $29
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Feb-26-21 07:00AM  
Feb-23-21 07:00AM  
Feb-04-21 07:00AM  
Jan-22-21 07:00AM  
Jan-05-21 07:00AM  
Dec-23-20 08:29AM  
Dec-22-20 04:05PM  
Dec-17-20 08:00AM  
Dec-14-20 07:07AM  
07:00AM  
Dec-04-20 07:00AM  
Dec-03-20 02:45AM  
Nov-16-20 05:34PM  
Nov-09-20 07:00AM  
Nov-04-20 09:32PM  
05:35PM  
04:25PM  
04:00PM  
02:30PM  
Oct-28-20 07:00AM  
Oct-26-20 07:23AM  
07:00AM  
Sep-21-20 09:04AM  
Sep-18-20 07:00AM  
Sep-17-20 09:41AM  
Sep-16-20 08:42AM  
Sep-14-20 07:00AM  
Sep-08-20 07:00AM  
Sep-04-20 02:21PM  
Aug-10-20 08:30PM  
05:35PM  
04:00PM  
Aug-05-20 04:00PM  
Aug-03-20 07:00AM  
Jul-30-20 12:59PM  
07:00AM  
Jul-29-20 04:27PM  
Jul-28-20 12:00PM  
08:44AM  
03:32AM  
Jul-27-20 04:00PM  
Jul-16-20 09:00AM  
Jul-02-20 08:51AM  
Jun-25-20 11:23AM  
Jun-22-20 09:00AM  
Jun-21-20 10:39PM  
Jun-17-20 07:58PM  
Jun-16-20 07:00AM  
Jun-06-20 11:31AM  
Jun-05-20 03:37AM  
Jun-03-20 04:00PM  
May-27-20 07:00AM  
May-11-20 10:41AM  
May-08-20 11:00PM  
May-07-20 04:00PM  
May-01-20 07:00AM  
Apr-30-20 07:00AM  
Apr-28-20 07:00AM  
Apr-23-20 07:00AM  
Apr-21-20 07:00AM  
Apr-14-20 10:37AM  
Mar-28-20 11:30AM  
Mar-17-20 11:12AM  
07:00AM  
Mar-11-20 07:00AM  
Mar-03-20 07:00AM  
Mar-02-20 08:00AM  
Feb-28-20 08:46AM  
Feb-27-20 04:00PM  
Feb-20-20 09:27AM  
07:00AM  
Feb-06-20 07:00AM  
Jan-17-20 05:50PM  
Jan-15-20 01:39PM  
Dec-27-19 02:50PM  
08:05AM  
07:59AM  
06:56AM  
Dec-26-19 03:57PM  
02:09PM  
08:33AM  
07:55AM  
07:00AM  
05:57AM  
Dec-17-19 10:01AM  
Dec-11-19 03:27PM  
Dec-07-19 11:31AM  
Dec-05-19 06:32AM  
Nov-27-19 08:44AM  
Nov-16-19 09:40PM  
Nov-14-19 09:57AM  
Nov-08-19 10:08AM  
Nov-07-19 04:00PM  
Oct-31-19 07:00AM  
Oct-28-19 04:21PM  
Oct-24-19 04:00PM  
Oct-23-19 11:16AM  
Oct-04-19 07:00AM  
Oct-01-19 02:58PM  
Sep-27-19 11:03AM  
Spectrum Pharmaceuticals, Inc., a biopharma company, develops and commercializes oncology and hematology drug products. The company is developing ROLONTIS, a novel long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of relapsed or refractory non-Hodgkin's lymphoma patients, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. for interferon therapeutics drug delivery platform. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Turgeon Joseph W.CEO & PresidentFeb 22Sale3.737,50027,975633,362Feb 23 05:00 PM
Riga Thomas JEVP, COO & CCOFeb 22Sale3.735,00018,650454,650Feb 23 04:19 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerFeb 22Sale3.734,00014,920437,134Feb 23 04:27 PM
McGahan Keith MChief Legal OfficerFeb 22Sale3.734,00014,920347,512Feb 23 04:33 PM
McGahan Keith MChief Legal OfficerFeb 19Sale3.643,29511,984351,512Feb 23 04:33 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerFeb 19Sale3.644,67216,992441,134Feb 23 04:27 PM
Riga Thomas JEVP, COO & CCOFeb 19Sale3.645,01818,250459,650Feb 23 04:19 PM
Turgeon Joseph W.CEO & PresidentFeb 19Sale3.647,25726,394640,862Feb 23 05:00 PM
McGahan Keith MChief Legal OfficerFeb 10Sale3.932,5009,825244,498Feb 10 05:29 PM
McGahan Keith MChief Legal OfficerFeb 09Sale3.931,9777,770246,998Feb 10 05:29 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 20Sale4.311,9448,379330,608Jan 20 08:33 PM
Riga Thomas JEVP, COO & CCOJan 20Sale4.3110,00043,100330,258Jan 20 08:34 PM
Turgeon Joseph W.CEO & PresidentJan 20Sale4.313,88916,762370,029Jan 20 08:33 PM
Turgeon Joseph W.CEO & PresidentJan 19Sale3.813,84414,638373,918Jan 20 08:33 PM
Riga Thomas JEVP, COO & CCOJan 19Sale3.9776,283302,894340,258Jan 20 08:34 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 19Sale3.812,5829,832332,552Jan 20 08:33 PM
Turgeon Joseph W.CEO & PresidentDec 16Sale4.70150,899709,225377,762Dec 18 07:18 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerDec 14Sale5.0025,696128,480335,134Dec 16 05:16 PM
Turgeon Joseph W.CEO & PresidentNov 18Sale4.13162,473671,013528,661Nov 20 05:10 PM
LEBEL FRANCOISChief Medical OfficerNov 09Sale3.565,00017,800306,424Nov 09 08:08 PM
LEBEL FRANCOISChief Medical OfficerNov 06Sale3.507,02524,609301,424Nov 09 08:08 PM
McGahan Keith MChief Legal OfficerAug 12Sale3.71250928248,769Aug 12 05:44 PM
McGahan Keith MChief Legal OfficerAug 11Sale4.032941,183249,019Aug 12 05:44 PM
McGahan Keith MChief Legal OfficerJul 09Sale3.3613,88146,640249,313Jul 09 06:24 PM
McGahan Keith MChief Legal OfficerJun 24Sale3.2115,77350,631262,986Jun 25 05:01 PM
LEBEL FRANCOISChief Medical OfficerJun 23Sale3.354,16713,959292,729Jun 23 05:23 PM
LEBEL FRANCOISChief Medical OfficerJun 22Sale3.165,47417,320296,896Jun 23 05:23 PM
Ashton WilliamDirectorJun 22Sale3.255,00016,25041,666Jun 23 04:30 PM
McGahan Keith MChief Legal OfficerJun 22Sale3.253,0009,750278,759Jun 23 04:11 PM
McGahan Keith MChief Legal OfficerJun 19Sale3.133,45910,820281,759Jun 23 04:11 PM
Riga Thomas JEVP, COO & CCOMay 14Sale3.061,1253,443416,433May 15 06:40 PM
McGahan Keith MChief Legal OfficerMay 14Sale3.063501,071285,218May 15 06:35 PM
McGahan Keith MChief Legal OfficerMay 13Sale3.254001,298285,568May 15 06:35 PM
Riga Thomas JEVP, COO & CCOMay 13Sale3.252,0866,769417,558May 15 06:40 PM
LEBEL FRANCOISChief Medical OfficerApr 03Sale2.188541,862302,370Apr 06 04:28 PM
LEBEL FRANCOISChief Medical OfficerApr 02Sale2.171,2282,667303,224Apr 06 04:28 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerApr 01Sale2.233,1356,991360,830Apr 02 06:16 PM
McGahan Keith MChief Legal OfficerApr 01Sale2.231,4673,271285,968Apr 02 06:18 PM
Riga Thomas JEVP, COO & CCOApr 01Sale2.239382,092419,644Apr 02 06:19 PM
Turgeon Joseph W.CEO & PresidentApr 01Sale2.232,5025,579691,134Apr 02 06:21 PM
Turgeon Joseph W.CEO & PresidentMar 31Sale2.314,0599,372693,636Apr 02 06:21 PM
Riga Thomas JEVP, COO & CCOMar 31Sale2.311,8544,281420,582Apr 02 06:19 PM
McGahan Keith MChief Legal OfficerMar 31Sale2.311,7864,124287,435Apr 02 06:18 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 31Sale2.314,3269,989363,965Apr 02 06:16 PM